Upcoming: HymonBio Will Participate in the 2023 CACLP and Co-Host the Thematic Academic Forum of the Voice of China Experimental Medicine Conference

News

Upcoming: HymonBio Will Participate in the 2023 CACLP and Co-Host the Thematic Academic Forum of the Voice of China Experimental Medicine Conference

The 20th China International Laboratory Medicine and Blood Transfusion Instrument and Reagent Expo (CACLP) and the 3rd China International IVD Upstream Raw Material Manufacturing and Distribution Supply Chain Expo (CISCE) will be held in Nanchang Greenland International Expo Center from May 28 to 30, 2023. HymonBio will bring a full range of innovative products to the exhibition, and look forward to your presence!

At the same time, HymonBio Co., Ltd. will co-sponsor the Voice of China Experimental Medicine Conference Thematic Academic Forum, with the theme of “Multidisciplinary Cooperation to Promote the Advancement of Cancer Prevention and Treatment – Frontier Progress and Clinical Advancement of Tumor Markers”, to explore the integration of resources, scientific cancer prevention, and precise cancer prevention. The chairman of the forum is Professor Dong Shukui of the Laboratory Medicine Branch of the Bethune Spiritual Research Association, Chairman of the Experimental Medical Science and Technology Transformation Committee, Professor He Jinchun of the First Hospital of Lanzhou University, and Dr. Tammy Tan, member of the Experimental Medical Science and Technology Transformation Committee and chairman of HymonBio Co., Ltd. The forum is exclusively sponsored and supported by HymonBio Co., Ltd.

WeChat Image_20230403095143

WeChat Image_20230403095149

This forum brought together many clinical and laboratory experts, both at home and abroad, focusing on the issue of advancing cancer prevention and treatment, and bringing the latest clinical research progress of tumor markers and an academic feast of innovative, multi-disciplinary cutting-edge technologies.  Many experts will introduce the integration of such technologies with early screening, clinical basic research, and early diagnosis molecular markers to explore in-depth and multi-dimensionally for cancer prevention and treatment, so as to help promote early screening and help the construction of a healthy China.

Exhibition Name: The 20th China International Laboratory Medicine and Blood Transfusion Instrument Reagent Expo (CACLP)

Exhibition Date: May 28-30, 2023

Exhibition Location: Nanchang Greenland International Expo Center

HymonBio Booth: A4-1423

WeChat Image_20230403095152

About HymonBio Co., Ltd.

The founder of HymonBio Co., Ltd. is a doctor from the Chinese Academy of Sciences. The company focuses on the development, production and sales of molecular diagnostic reagents and POCT related products. The company has applied for 31 patents and obtained 6 authorized patents, 11 products have obtained the Chinese medical device certificate, 9 products have obtained the EU CE certificate, 1 product has obtained the US FDA certificate, and has passed the ISO13485 system certification. The company has successively been rated as a national high-tech enterprise, a research and development oriented enterprise in Jiangsu Province, a private technology enterprise in Jiangsu Province, an enterprise supported by the ” Double Innovation Plan” in Jiangsu Province, and a leading talent enterprise in innovation and entrepreneurship in Suzhou. HymonBio has completed Series A financing, which is the first outbound investment project in China by PerkinElmer Venture Capital, a leading enterprise in the IVD industry.


Post time: Mar-29-2023